NDAINJECTIONINJECTABLE
Lifecycle
Pre-Launch
Data completeness
2/8 — Basic
DEPINAR (cyanocobalamin; tannic acid; zinc acetate) by R-Pharm US is clinical pharmacology vitamin b 12 is essential to growth, cell reproduction, hematopoiesis, and nucleoprotein and myelin synthesis. Approved for anemia.
Drug data last refreshed 4h ago · AI intelligence enriched 1mo ago
AI summarySynthesized from FDA + DailyMed + ClinicalTrials.gov data
DEPINAR is a fixed-dose injectable combination of cyanocobalamin (vitamin B12), tannic acid, and zinc acetate indicated for anemia treatment. Cyanocobalamin is essential for cell reproduction, hematopoiesis, and myelin synthesis, with rapid intramuscular/subcutaneous absorption reaching peak plasma levels within 1 hour. The product addresses vitamin B12 deficiency including pernicious anemia and malabsorption-related cases where oral therapy is unreliable.
Pre-Launch
Early-stage product with no commercialization data; opportunities exist in launch planning, market access, and medical affairs as company prepares market entry.
Mechanism of Action
CLINICAL PHARMACOLOGY Vitamin B 12 is essential to growth, cell reproduction, hematopoiesis, and nucleoprotein and myelin synthesis. Cyanocobalamin is quantitatively and rapidly absorbed from intramuscular and subcutaneous sites of injection; the plasma level of the compound reaches its peak within…
Worked on DEPINAR at R-Pharm US? Share your interview experience or compensation data (+7 days Pro)
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.